416 related articles for article (PubMed ID: 27724856)
1. Aldehyde dehydrogenase activity plays a Key role in the aggressive phenotype of neuroblastoma.
Flahaut M; Jauquier N; Chevalier N; Nardou K; Balmas Bourloud K; Joseph JM; Barras D; Widmann C; Gross N; Renella R; Mühlethaler-Mottet A
BMC Cancer; 2016 Oct; 16(1):781. PubMed ID: 27724856
[TBL] [Abstract][Full Text] [Related]
2. The enzymatic activity of human aldehyde dehydrogenases 1A2 and 2 (ALDH1A2 and ALDH2) is detected by Aldefluor, inhibited by diethylaminobenzaldehyde and has significant effects on cell proliferation and drug resistance.
Moreb JS; Ucar D; Han S; Amory JK; Goldstein AS; Ostmark B; Chang LJ
Chem Biol Interact; 2012 Jan; 195(1):52-60. PubMed ID: 22079344
[TBL] [Abstract][Full Text] [Related]
3. Differential Functional Roles of ALDH1A1 and ALDH1A3 in Mediating Metastatic Behavior and Therapy Resistance of Human Breast Cancer Cells.
Croker AK; Rodriguez-Torres M; Xia Y; Pardhan S; Leong HS; Lewis JD; Allan AL
Int J Mol Sci; 2017 Sep; 18(10):. PubMed ID: 28937653
[TBL] [Abstract][Full Text] [Related]
4. Clinical implications of ALDH1A1 and ALDH1A3 mRNA expression in melanoma subtypes.
Samson JM; Ravindran Menon D; Smith DE; Baird E; Kitano T; Gao D; Tan AC; Fujita M
Chem Biol Interact; 2019 Dec; 314():108822. PubMed ID: 31580832
[TBL] [Abstract][Full Text] [Related]
5. Human articular chondrocytes with higher aldehyde dehydrogenase activity have stronger expression of COL2A1 and SOX9.
Unguryte A; Bernotiene E; Bagdonas E; Garberyte S; Porvaneckas N; Jorgensen C
Osteoarthritis Cartilage; 2016 May; 24(5):873-82. PubMed ID: 26687820
[TBL] [Abstract][Full Text] [Related]
6. Inhibitors of aldehyde dehydrogenases of the 1A subfamily as putative anticancer agents: Kinetic characterization and effect on human cancer cells.
Jiménez R; Pequerul R; Amor A; Lorenzo J; Metwally K; Avilés FX; Parés X; Farrés J
Chem Biol Interact; 2019 Jun; 306():123-130. PubMed ID: 30958995
[TBL] [Abstract][Full Text] [Related]
7. Distinct prognostic values and potential drug targets of ALDH1 isoenzymes in non-small-cell lung cancer.
You Q; Guo H; Xu D
Drug Des Devel Ther; 2015; 9():5087-97. PubMed ID: 26366059
[TBL] [Abstract][Full Text] [Related]
8. N,N-diethylaminobenzaldehyde (DEAB) as a substrate and mechanism-based inhibitor for human ALDH isoenzymes.
Morgan CA; Parajuli B; Buchman CD; Dria K; Hurley TD
Chem Biol Interact; 2015 Jun; 234():18-28. PubMed ID: 25512087
[TBL] [Abstract][Full Text] [Related]
9. Distinct expression patterns and roles of aldehyde dehydrogenases in normal oral mucosa keratinocytes: differential inhibitory effects of a pharmacological inhibitor and RNAi-mediated knockdown on cellular phenotype and epithelial morphology.
Kato H; Izumi K; Saito T; Ohnuki H; Terada M; Kawano Y; Nozawa-Inoue K; Saito C; Maeda T
Histochem Cell Biol; 2013 Jun; 139(6):847-62. PubMed ID: 23250514
[TBL] [Abstract][Full Text] [Related]
10. Essential role of aldehyde dehydrogenase 1A3 for the maintenance of non-small cell lung cancer stem cells is associated with the STAT3 pathway.
Shao C; Sullivan JP; Girard L; Augustyn A; Yenerall P; Rodriguez-Canales J; Liu H; Behrens C; Shay JW; Wistuba II; Minna JD
Clin Cancer Res; 2014 Aug; 20(15):4154-66. PubMed ID: 24907115
[TBL] [Abstract][Full Text] [Related]
11. Aldehyde dehydrogenase activity of breast cancer stem cells is primarily due to isoform ALDH1A3 and its expression is predictive of metastasis.
Marcato P; Dean CA; Pan D; Araslanova R; Gillis M; Joshi M; Helyer L; Pan L; Leidal A; Gujar S; Giacomantonio CA; Lee PW
Stem Cells; 2011 Jan; 29(1):32-45. PubMed ID: 21280157
[TBL] [Abstract][Full Text] [Related]
12. ALDH1A1 drives prostate cancer metastases and radioresistance by interplay with AR- and RAR-dependent transcription.
Gorodetska I; Offermann A; Püschel J; Lukiyanchuk V; Gaete D; Kurzyukova A; Freytag V; Haider MT; Fjeldbo CS; Di Gaetano S; Schwarz FM; Patil S; Borkowetz A; Erb HHH; Baniahmad A; Mircetic J; Lyng H; Löck S; Linge A; Lange T; Knopf F; Wielockx B; Krause M; Perner S; Dubrovska A
Theranostics; 2024; 14(2):714-737. PubMed ID: 38169509
[No Abstract] [Full Text] [Related]
13. Dual disruption of aldehyde dehydrogenases 1 and 3 promotes functional changes in the glutathione redox system and enhances chemosensitivity in nonsmall cell lung cancer.
Rebollido-Rios R; Venton G; Sánchez-Redondo S; Iglesias I Felip C; Fournet G; González E; Romero Fernández W; Borroto Escuela DO; Di Stefano B; Penarroche-Díaz R; Martin G; Ceylan I; Costello R; Perez-Alea M
Oncogene; 2020 Mar; 39(13):2756-2771. PubMed ID: 32015486
[TBL] [Abstract][Full Text] [Related]
14. Targeting ALDH(bright) human carcinoma-initiating cells with ALDH1A1-specific CD8⁺ T cells.
Visus C; Wang Y; Lozano-Leon A; Ferris RL; Silver S; Szczepanski MJ; Brand RE; Ferrone CR; Whiteside TL; Ferrone S; DeLeo AB; Wang X
Clin Cancer Res; 2011 Oct; 17(19):6174-84. PubMed ID: 21856769
[TBL] [Abstract][Full Text] [Related]
15. Aldehyde dehydrogenase 1A1 in stem cells and cancer.
Tomita H; Tanaka K; Tanaka T; Hara A
Oncotarget; 2016 Mar; 7(10):11018-32. PubMed ID: 26783961
[TBL] [Abstract][Full Text] [Related]
16. Aldehyde dehydrogenase 1A1 and 1A3 isoforms - mechanism of activation and regulation in cancer.
Poturnajova M; Kozovska Z; Matuskova M
Cell Signal; 2021 Nov; 87():110120. PubMed ID: 34428540
[TBL] [Abstract][Full Text] [Related]
17. Structural and kinetic features of aldehyde dehydrogenase 1A (ALDH1A) subfamily members, cancer stem cell markers active in retinoic acid biosynthesis.
Pequerul R; Vera J; Giménez-Dejoz J; Crespo I; Coines J; Porté S; Rovira C; Parés X; Farrés J
Arch Biochem Biophys; 2020 Mar; 681():108256. PubMed ID: 31923393
[TBL] [Abstract][Full Text] [Related]
18. ALDH1A1 and ALDH1A3 paralogues of aldehyde dehydrogenase 1 control myogenic differentiation of skeletal muscle satellite cells by retinoic acid-dependent and -independent mechanisms.
Steingruber L; Krabichler F; Franzmeier S; Wu W; Schlegel J; Koch M
Cell Tissue Res; 2023 Dec; 394(3):515-528. PubMed ID: 37904003
[TBL] [Abstract][Full Text] [Related]
19. Aldehyde dehydrogenase 1A3 influences breast cancer progression via differential retinoic acid signaling.
Marcato P; Dean CA; Liu RZ; Coyle KM; Bydoun M; Wallace M; Clements D; Turner C; Mathenge EG; Gujar SA; Giacomantonio CA; Mackey JR; Godbout R; Lee PW
Mol Oncol; 2015 Jan; 9(1):17-31. PubMed ID: 25106087
[TBL] [Abstract][Full Text] [Related]
20. ALDH1A inhibition sensitizes colon cancer cells to chemotherapy.
Kozovska Z; Patsalias A; Bajzik V; Durinikova E; Demkova L; Jargasova S; Smolkova B; Plava J; Kucerova L; Matuskova M
BMC Cancer; 2018 Jun; 18(1):656. PubMed ID: 29902974
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]